Daniel Munoz
Overview
Explore the profile of Daniel Munoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
4218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Narcisse D, Kim H, Wruck L, Stebbins A, Munoz D, Kripalani S, et al.
Diabetes Care
. 2023 Sep;
47(1):81-88.
PMID: 37713477
Objective: Patients with diabetes mellitus (DM) and concomitant atherosclerotic cardiovascular disease (ASCVD) must be on the most effective dose of aspirin to mitigate risk of future adverse cardiovascular events. Research...
12.
Shen R, Mulder H, Wruck L, Weissler E, Robertson H, Sharlow A, et al.
J Am Heart Assoc
. 2023 Jun;
12(13):e027899.
PMID: 37345815
Background Internet-based participation has the potential to enhance pragmatic and decentralized trials, where representative study populations and generalizability to clinical practice are key. We aimed to study the differences between...
13.
Gupta K, Mehta H, Kim H, Stebbins A, Wruck L, Munoz D, et al.
Am Heart J
. 2023 Jun;
264:31-39.
PMID: 37290700
Background: Among patients with established cardiovascular disease, the ADAPTABLE trial found no significant differences in cardiovascular events and bleeding rates between 81 mg and 325 mg of aspirin (ASA) daily....
14.
Weissler E, Stebbins A, Wruck L, Munoz D, Gupta K, Girotra S, et al.
Vasc Med
. 2023 Apr;
28(2):122-130.
PMID: 37025023
Background: We aimed to understand the effects of aspirin dose on outcomes in patients with peripheral artery disease (PAD) as well as their participation in a pragmatic randomized controlled trial....
15.
Soldevila-Domenech N, Pastor A, Sala-Vila A, Lazaro I, Boronat A, Munoz D, et al.
Front Nutr
. 2022 Dec;
9:1076677.
PMID: 36532543
Background: Excess circulating endocannabinoids (eCBs) and imbalanced -acylethanolamines (NAEs) related eCBs abundance could influence dietary weight loss success. We aimed to examine sex differences in the impact of a 3-years...
16.
Navar A, Fine L, Ambrosius W, Brown A, Douglas P, Johnson K, et al.
Am J Prev Cardiol
. 2022 Nov;
12:100430.
PMID: 36439649
Disclosures: The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes...
17.
Reyes G, Munoz D, Monguio E, Berastegui E, Camara M, de Antonio N, et al.
Eur J Cardiothorac Surg
. 2022 Mar;
62(5).
PMID: 35348660
Objectives: This study reports long-term clinical outcomes-up to 17 years-among patients undergoing mitral valve replacement with the On-X bileaflet mechanical valve. Prior data regarding long-term outcomes with the On-X mitral...
18.
Contreras-Castillo S, Plaza A, Stojanova J, Navarro G, Carmona R, Corvalan F, et al.
Front Pharmacol
. 2021 Dec;
12:674117.
PMID: 34938174
Cyclosporine (CsA) and tacrolimus (TAC) are immunosuppressant drugs characterized by a narrow therapeutic range and high pharmacokinetic variability. The effect of polymorphisms in genes related to the metabolism and transport...
19.
Jones W, Mulder H, Wruck L, Pencina M, Kripalani S, Munoz D, et al.
N Engl J Med
. 2021 May;
384(21):1981-1990.
PMID: 33999548
Background: The appropriate dose of aspirin to lower the risk of death, myocardial infarction, and stroke and to minimize major bleeding in patients with established atherosclerotic cardiovascular disease is a...
20.
Ward M, Vogus T, Munoz D, Collins S, Moser K, Jenkins C, et al.
West J Emerg Med
. 2021 Apr;
22(2):319-325.
PMID: 33856318
Introduction: Despite large-scale quality improvement initiatives, substantial proportions of patients with ST-elevation myocardial infarction (STEMI) transferred to percutaneous coronary intervention centers do not receive percutaneous coronary intervention within the recommended...